Cristin L. Rothfuss

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Cristin L. Rothfuss
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Cristin L. Rothfuss:

Company Role Class Num Shares Value Price $ Report Date Ownership
Sarepta Therapeutics, Inc. EVP, General Counsel Common Stock 139,756 $2,951,646 $21.12 28 Nov 2025 Direct
Sarepta Therapeutics, Inc. EVP, General Counsel Stock Options (right to buy) 16,644 10 Mar 2025 Direct

Insider Reports Filed by Cristin L. Rothfuss

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SRPT Sarepta Therapeutics, Inc. 28 Nov 2025 1 -$4,836 4 EVP, General Counsel 02 Dec 2025, 20:02
SRPT Sarepta Therapeutics, Inc. 03 Sep 2025 2 $0 4 EVP, General Counsel 05 Sep 2025, 21:30
SRPT Sarepta Therapeutics, Inc. 10 Mar 2025 3 -$49,164 4 EVP, General Counsel 11 Mar 2025, 20:00
SRPT Sarepta Therapeutics, Inc. 07 Mar 2025 2 -$153,269 4 EVP, General Counsel 10 Mar 2025, 20:00
SRPT Sarepta Therapeutics, Inc. 04 Mar 2025 2 -$59,183 4 EVP, General Counsel 06 Mar 2025, 20:00
SRPT Sarepta Therapeutics, Inc. 03 Mar 2025 1 -$40,574 4 EVP, General Counsel 04 Mar 2025, 20:00
SRPT Sarepta Therapeutics, Inc. 26 Nov 2024 2 $0 4 EVP, General Counsel 29 Nov 2024, 20:15
SRPT Sarepta Therapeutics, Inc. 26 Nov 2024 0 $0 3 EVP, General Counsel 29 Nov 2024, 20:00